Skip to main content
. 1998 Feb 3;95(3):930–932. doi: 10.1073/pnas.95.3.930

Figure 2.

Figure 2

Prion formation can be inhibited either by ligand binding to PrPc, which shifts the equilibrium toward Prpc under cellular conditions that normally would form the prionogenic intermediate (Upper; also see ref. 35), or by using peptidomimetics that bind to the prionogenic intermediate or other intermediates that precede prion formation (not shown).